International Medical Journal, Vol. 14., Iss. 1, 2008, P. 71−78.
ADVANTAGES OF COMBINATION DRUG THERAPY IN CORRECTION OF DYSLIPIDEMIA IN METABOLIC SYNDROME AND TYPE 2 DIABETES MELLITUS
Kharkiv National Medical University, Kharkiv, Ukraine
The necessity of combined therapy with statins/fibrates for control of lipid metabolism disorders at metabolic syndrome and diabetes mellitus is shown.
Key words: metabolic syndrome, hypolipidemic therapy, statins, fibrates.